GERN Price / Book | GERON CORP

GERON CORP (GERN) Price / Book

2026-09-03: Price/Book Ratio 4.42.
2026-06-30: Price/Book Ratio 3.76.
2026-03-31: Price/Book Ratio 4.17.
2025-12-31: Price/Book Ratio 3.74.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.42
2026-06-30	3.76
2026-03-31	4.17
2025-12-31	3.74
2025-09-30	3.51
2025-06-30	3.46
2025-03-31	3.78
2024-12-31	7.66
2024-09-30	9.36
2024-06-30	8.2
2024-03-31	5.23
2023-12-31	4.64
2023-09-30	3.82
2023-06-30	5.47
2023-03-31	3.39
2022-12-31	11.81
2022-09-30	8.25
2022-06-30	4.12
2022-03-31	4.52
2021-12-31	3.12
2021-09-30	2.9
2021-06-30	2.55
2021-03-31	2.5
2020-12-31	2.34
2020-09-30	2.32
2020-06-30	1.77
2020-03-31	1.97
2019-12-31	2.01
2019-09-30	1.64
2019-06-30	1.67
2019-03-31	1.83
2018-12-31	1.05
2018-09-30	1.76
2018-06-30	3.33
2018-03-31	6.75
2017-12-31	2.77
2017-09-30	3.21
2017-06-30	3.9
2017-03-31	3.08
2016-12-31	2.69
2016-09-30	2.79
2016-06-30	3.27
2016-03-31	3.4
2015-12-31	5.41
2015-09-30	2.95
2015-06-30	5.72
2015-03-31	4.75
2014-12-31	3.91
2014-09-30	2.29
2014-06-30	3.29
2014-03-31	2.05
2013-12-31	9.8
2013-09-30	6.58
2013-06-30	2.7
2013-03-31	1.74
2012-12-31	2.03
2012-09-30	2.13
2012-06-30	1.87
2012-03-31	1.63
2011-12-31	1.25
2011-09-30	1.5
2010-12-31	3.12

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Faeth Therapeutics, Inc. (FTH)	United States	$0.750B